Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

Scientists have harnessed artificial-intelligence models to create synthetic CRISPR proteins that edit the genome more efficiently than their naturally occurring counterparts. Such synthetic CRISPR ...

Researchers developed DiscERN, a genome-mining platform that combines four complementary algorithms to identify ...

The tests are intended for infectious and chronic disease detection and diagnosis as well as to aid in routine health monitoring.